Suzanne E Mahady
Overview
Explore the profile of Suzanne E Mahady including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
750
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Li D, Cheng D, Parks A, Rieu-Werden M, Polekhina G, Mahady S, et al.
J Thromb Haemost
. 2025 Feb;
PMID: 39986609
Background: Clinically significant extracranial bleeding, defined as bleeding at any site other than the brain or spinal cord requiring either a hospital admission >24 hours, red blood cell transfusion, surgery...
2.
Mahady S, Polekhina G, Woods R, Wolfe R, Wetmore J, Margolis K, et al.
Kidney Int Rep
. 2023 Apr;
8(4):737-745.
PMID: 37069989
Introduction: Data on the association between chronic kidney disease (CKD) and major hemorrhage in older adults are lacking. Methods: We used data from a double-blind randomized controlled trial of aspirin...
3.
Downie J, Riaz M, Xie J, Lee M, Chan A, Gibbs P, et al.
Cancer Prev Res (Phila)
. 2022 May;
15(8):509-519.
PMID: 35609203
Prevention Relevance: Despite absence of loss of heterozygosity in colorectal cancers, elderly male MUTYH carriers appeared to be at increased of colorectal cancer.
4.
Wolfe R, Wetmore J, Woods R, McNeil J, Gallagher H, Roderick P, et al.
Kidney Int
. 2020 Sep;
99(2):466-474.
PMID: 32920022
The role of aspirin for primary prevention in older adults with chronic kidney disease (CKD) is unclear. Therefore, post hoc analysis of the randomized controlled trial ASPirin in Reducing Events...
5.
Mahady S, Margolis K, Chan A, Polekhina G, Woods R, Wolfe R, et al.
Gut
. 2020 Aug;
70(4):717-724.
PMID: 32747412
Objective: There is a lack of robust data on significant gastrointestinal bleeding in older people using aspirin. We calculated the incidence, risk factors and absolute risk using data from a...
6.
Mahady S, Woods R, Wolfe R, Nelson M, Murray A, McNeil J
Am J Med
. 2020 Jul;
133(7):e389-e390.
PMID: 32600553
No abstract available.
7.
Adams L, Roberts S, Strasser S, Mahady S, Powell E, Estes C, et al.
J Gastroenterol Hepatol
. 2020 Feb;
35(9):1628-1635.
PMID: 32048317
Background And Aim: Nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) account for a large and growing proportion of liver disease burden globally. The burden of NAFLD/NASH manifests in...
8.
Feletto E, Yu X, Lew J, St John D, Jenkins M, Macrae F, et al.
Cancer Epidemiol Biomarkers Prev
. 2018 Dec;
28(1):83-90.
PMID: 30530848
Background: Colorectal cancer is the third most commonly diagnosed cancer in Australia. Emerging evidence from several countries suggests increasing incidence in people aged <50 years. Methods: We assessed colon and...
9.
McNeil J, Wolfe R, Woods R, Tonkin A, Donnan G, Nelson M, et al.
N Engl J Med
. 2018 Sep;
379(16):1509-1518.
PMID: 30221597
Background: Aspirin is a well-established therapy for the secondary prevention of cardiovascular events. However, its role in the primary prevention of cardiovascular disease is unclear, especially in older persons, who...
10.